Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Taelman

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Journal of Rheumatology|April 1, 1997
Body composition in rheumatoid arthritisR Westhovens, J Nijs, V Taelman, et al.
Mechanisms of Development|March 7, 2001
Xath2, a bHLH gene expressed during a late transition stage of neurogenesis in the forebrain of Xenopus embryosV Taelman, K Opdecamp, B Avalosse, et al.
Scandinavian Journal of Rheumatology|September 13, 2021
Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trialD Bertrand, V Stouten, D De Cock, et al.
Annals of the Rheumatic Diseases|November 1, 2014
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trialP Verschueren, D De Cock, L Corluy, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Journal of Rheumatology|April 1, 1997
Body composition in rheumatoid arthritisR Westhovens, J Nijs, V Taelman, et al.
Mechanisms of Development|March 7, 2001
Xath2, a bHLH gene expressed during a late transition stage of neurogenesis in the forebrain of Xenopus embryosV Taelman, K Opdecamp, B Avalosse, et al.
Scandinavian Journal of Rheumatology|September 13, 2021
Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trialD Bertrand, V Stouten, D De Cock, et al.
Annals of the Rheumatic Diseases|November 1, 2014
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trialP Verschueren, D De Cock, L Corluy, et al.
Pageof 1